Skip to main content

Table 3 Immunosuppressive and immunomodulatory treatments at the time of blood sampling (N = 37) in patients (N = 25) with Susac syndrome (SuS), stratified according to anti-endothelial cell antibodies (AECA) serostatus

From: Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study

  SuS samples, total SuS samples, AECA-positive SuS samples, AECA-negative
Untreated 19 4 15
Treateda 16 6 10
  Steroids 11 3 8
  IVIG 6 3 4
  Azathioprine 2 0 2
  Cyclophosphamide 3 0 3
  Mycophenolate mofetil 3 2 1
  Methotrexate 1 1 0
  Unknown 2 1 1
  1. aNote that the values in rows 3 to 8 of each column do not sum up to the values given in row 2 of the same column, since some patients received more than immunosuppressive/immunomodulatory treatment at the time of blood sampling. AECA, anti-endothelial cell antibodies; IVIG, intravenous immunoglobulins; SuS, Susac syndrome.